Answers are grounded in this paper and cite their sources.
Computational modeling study demonstrates that region-aware CDR masking improves antibody binding affinity prediction by up to 27%, highlighting the efficiency of paired-sequence training.
Therapeutic antibodies are a leading class of biologics, yet their unique architecture poses challenges for computational modeling. Each antibody comprises paired heavy and light variable domains with conserved framework regions that maintain structure and hypervariable complementarity-determining regions (CDRs) that directly contact antigens. This functional asymmetry, where CDRs determine binding specificity while frameworks provide scaffolding, suggests that region-aware training strategies could yield superior representations. Existing protein language models treat all regions uniformly, potentially missing critical features present in CDRs. We developed a region-aware pretraining strategy for paired variable-domain sequences using two protein language models: a 3-billion-parameter model (ESM2) and a compact 600-million-parameter model (ESM C). We compared three masking approaches: uniform whole-chain masking, CDR-focused masking, and a hybrid strategy. Final models were trained on over 1.6 million paired antibody sequences and evaluated on binding affinity datasets with over 90,000 antibody variants across six antigens, including single-mutant panels and combinatorial libraries. Here we show that CDR-focused training produces embeddings with superior predictive performance for antibody–antigen binding. Our approach achieves up to 27% improvements in binding affinity prediction compared to benchmarked antibody models. Remarkably, training exclusively on paired sequences proves sufficient; pretraining on billions of unpaired sequences provides no measurable benefit. Our compact model matches or exceeds larger antibody-specific baselines. These findings establish that prioritizing paired sequences with CDR-aware supervision over scale and complex training schemes achieves both computational efficiency and predictive accuracy, providing a practical framework for next-generation antibody language models.
No takes yet. Share an insight, caveat, or question.
Talaei et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: